Model predicts combo therapy may cure hepatitis C in 2 months
New modeling data predict that bemnifosbuvir and ruzasvir, an experimental combination treatment being developed by Atea Pharmaceuticals for chronic hepatitis C, may…
Hepatitis is a broad term that refers to liver inflammation. There are several types of hepatitis with different underlying causes — the most common forms occur due to a viral infection, while other types are due to an autoimmune reaction or toxins that damage the liver.
Read moreHepatitis refers to inflammation of the liver. There are several types of hepatitis, and the disease can cause a wide range of manifestations; some people may have mild hepatitis symptoms that don’t cause notable issues, while others may have life-threatening liver problems.
Read moreNew modeling data predict that bemnifosbuvir and ruzasvir, an experimental combination treatment being developed by Atea Pharmaceuticals for chronic hepatitis C, may…
PBGENE-HBV, Precision BioSciences’ experimental gene-editing therapy for chronic hepatitis B, showed antiviral activity across three doses, with the highest dose approaching the benchmark…